Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology

Clinical trial NCT01760291 · COMPLETED

Trial details

NCT number: NCT01760291
Sponsor: Boston Scientific Corporation
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2012-09-01
Primary completion: 2019-04-01
Enrollment: 576

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.